Lawrence Nguyen, OD
Optometrist · Omaha, NENPI 1205574472
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 85 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 23.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,208, 3.2 times the $383 reported in 2022. Among optometrist clinicians in NE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 85 payments — averaging $34.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tarsus Pharmaceuticals, Inc.$678
- Glaukos Corporation$584
- Alcon$290
- Oyster Point Pharma, Inc.$289
- AbbVie$219
- Amgen$169
- plus $720 from 10 others
What the payments were for
- Speaking & faculty fees$281%
- Food & beverage$2,92099%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tarsus Pharmaceuticals, Inc. | 17 | $678 |
| Glaukos Corporation | 14 | $584 |
| Alcon | 6 | $290 |
| Oyster Point Pharma, Inc. | 7 | $289 |
| AbbVie | 4 | $219 |
| Amgen(2 entities) | 5 | $169 |
| Bausch & Lomb Americas Inc. | 8 | $165 |
| Biotissue Holdings Inc. | 3 | $162 |
| Novartis | 8 | $122 |
| Mallinckrodt Hospital Products Inc. | 4 | $83 |
| Dompe US, Inc. | 3 | $57 |
| Sun Pharmaceutical Industries Inc. | 2 | $44 |
| Rxsight Inc | 1 | $28 |
| Rayner Intraocular Lenses Limited | 1 | $24 |
| Tearlab Corp | 1 | $20 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,948 in reported general payments places this provider in the 90th percentile of 383 optometrist providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lotemax SmLoteprednol Etabonate | 15 | $3,804 |
| Difluprednate | 22 | $2,500 |
| Prednisolone Acetate | 78 | $2,324 |
| Bromfenac Sodium | 12 | $2,125 |
| MoxifloxacinMoxifloxacin Hcl | 65 | $1,615 |
| Doxycycline Hyclate | 15 | $884 |
| Diclofenac Sodium | 16 | $186 |
| Latanoprost | 13 | $99 |
| Brimonidine Tartrate | 15 | $58 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Omaha
- Christopher WolfeOmaha$154K
- Mark ToelleOmaha$10K
- John GoertzOmaha$8K
- Jordan ArensOmaha$7K
- Holly TernusOmaha$6K
- Marsha KubicaOmaha$6K
- Delaney KentOmaha$5K
- Adam WalterOmaha$5K
- Kelly RobertsonOmaha$5K
- Kristen WaltonOmaha$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.